Work

Phase 2 Study of Ruxolitinib in Patients with Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-119476

Authors: Kim-Hien Dao, Robert H. Collins, Jorge E. Cortes, Michael W. Deininger, Brian J. Druker, Jason R. Gotlib, Tara Alyson Macey, Stephen T Oh, Jeffrey W. Tyner, Elliott F. Winton

Institutions: Oregon Health & Science University, The University of Texas Southwestern Medical Center, The University of Texas MD Anderson Cancer Center, University of Utah, OHSU Knight Cancer Institute, Stanford Medicine, Stanford University, Washington University in St. Louis, Emory University, Winship Cancer Institute

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2909890633

Cites:

Cited by: 5

Related to: 10